Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

Nature Medicine

Volumn 19, Issue 11, 2013, Pages 1469-1472

  Vaishnavi, Aria ^a   Capelletti, Marzia ^b   Le, Anh T ^a   Kako, Severine ^c   Butaney, Mohit ^b   Ercan, Dalia ^b   Mahale, Sakshi ^c   Davies, Kurtis D ^a   Aisner, Dara L ^a,c   Pilling, Amanda B ^a   Berge, Eamon M ^a   Kim, Jhingook ^d   Sasaki, Hidefumi ^e   Park, Seung Il ^f   Kryukov, Gregory ^g   Garraway, Levi A ^b,g   Hammerman, Peter S ^b   Haas, Julia ^h   Andrews, Steven W ^h   Lipson, Doron ⁱ   Stephens, Philip J ⁱ   Miller, Vince A ⁱ   Varella Garcia, Marileila ^a,c   Jänne, Pasi A ^b   Doebele, Robert C ^a,c   more..

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^f University of Ulsan   (South Korea)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h ARRAY BIOPHARMA INC   (United States)

ⁱ FOUNDATION MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARRY 470; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CD74 ANTIGEN; CRIZOTINIB; EPIDERMAL GROWTH FACTOR RECEPTOR; LESTAURTINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIC TYROSINE KINASE RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE FUSION; GENE SEQUENCE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELL LINE, TUMOR; GENE REARRANGEMENT; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; ONCOGENE FUSION; PROTEIN KINASE INHIBITORS; RECEPTOR, TRKA;

EID: 84887445619     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3352     Document Type: Article

References (36)

1. Mok, T.S. et al. N. Engl. J. Med. 361, 947-957 (2009).
2. Shaw, A.T. et al. N. Engl. J. Med. 368, 2385-2394 (2013).
3. Davies, K.D. et al. Clin. Cancer Res. 18, 4570-4579 (2012).
4. Takeuchi, K. et al. Nat. Med. 18, 378-381 (2012).
5. Ju, Y.S. et al. Genome Res. 22, 436-445 (2012).
6. Kohno, T. et al. Nat. Med. 18, 375-377 (2012).
7. Drilon, A. et al. Cancer Discov. 3, 630-635 (2013).
8. Majewski, I.J. et al. J. Pathol. 230, 270-276 (2013).
9. Wu, Y.M. et al. Cancer Discov. 3, 636-647 (2013).
10. Lipson, D. et al. Nat. Med. 18, 382-384 (2012).
11. Alberti, L., Carniti, C., Miranda, C., Roccato, E. & Pierotti, M.A. J. Cell Physiol. 195, 168-186 (2003).
12. Davies, K.D. & Doebele, R.C. Clin. Cancer Res. 19, 4040-4045 (2013).
13. Peifer, M. et al. Nat. Genet. 44, 1104-1110 (2012).
14. Stephens, R.M. et al. Neuron 12, 691-705 (1994).
15. Surks, H.K., Richards, C.T. & Mendelsohn, M.E. J. Biol. Chem. 278, 51484-51493 (2003).
16. Soda, M. et al. Nature 448, 561-566 (2007).
17. Busch, R., Doebele, R.C., Patil, N.S., Pashine, A. & Mellins, E.D. Curr. Opin. Immunol. 12, 99-106 (2000).
18. Rikova, K. et al. Cell 131, 1190-1203 (2007).
19. Awad, M.M. et al. N. Engl. J. Med. 369, 1173 (2013).
20. Martin-Zanca, D., Hughes, S.H. & Barbacid, M. Nature 319, 743-748 (1986).
21. Seo, J.S. et al. Genome Res. 22, 2109-2119 (2012).
22. George, D.J. et al. Cancer Res. 59, 2395-2401 (1999).
23. Cui, J.J. et al. J. Med. Chem. 54, 6342-6363 (2011).
24. Gnirke, A. et al. Nat. Biotechnol. 27, 182-189 (2009).
25. Li, H. et al. Bioinformatics 25, 2078-2079 (2009).
26. McKenna, A. et al. Genome Res. 20, 1297-1303 (2010).
27. Zhou, W. et al. Nature 462, 1070-1074 (2009).
28. Berger, M.F. et al. Genome Res. 20, 413-427 (2010).
29. Kim, D. et al. Genome Biol. 14, R36 (2013).
30. Doebele, R.C. et al. Clin. Cancer Res. 18, 1472-1482 (2012).
31. Helfrich, B.A. et al. Clin. Cancer Res. 12, 7117-7125 (2006).
32. Davies, K.D. et al. Clin. Cancer Res. 18, 4570-4579 (2012).
33. Marek, L. et al. Mol. Pharmacol. 75, 196-207 (2009).
34. Pitts, T.M. et al. Front Pharmacol. 4, 35 (2013).
35. Oie, H.K. et al. J. Cell Biochem. Suppl. 24, 24-31 (1996).
36. Sasaki, T. et al. Cancer Res. 71, 6051-6060 (2011)